2118P Perioperative sintilimab plus oxaliplatin and S-1 (SOX) versus SOX alone in resectable locally advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC): A multicenter randomized phase II study (PERSIST)
Xinfa Ding(Second Affiliated Hospital of Zhejiang University), Han Liang(Sun Yat-sen University), Jing Chai(Anhui Medical University), Qian Zhao(Hebei Medical University), Lei Shang, Jun Deng(Yale University), Li Wang, Ben Wang(Zhejiang Cancer Hospital), Bin Li(Wuhan University), Na Liu(Sun Yat-sen University), Rongrong Zhang(Central South University of Forestry and Technology), Min Cai(Xijing Hospital), Liwei Wu(Tianjin Medical University Cancer Institute and Hospital), Bin Ke(Tianjin Medical University Cancer Institute and Hospital), Xin Wang(Affiliated Hospital of Southwest Medical University), Tao Li(PowerChina (China)), Yaxin Liu(Tianjin Medical University Cancer Institute and Hospital)
Cited by 1
Related Papers
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
Deep convolutional neural networks for multi-modality isointense infant brain image segmentation
|NeuroImage|2015|830
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Deregulation of sphingolipid metabolism in Alzheimer's disease
|Neurobiology of Aging|2008|529